BG

Bimla Garg

Active Director Director DIN 09378445
DIN 09378445 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Bimla Garg

Data last updated:

Bimla Garg is a Director at Yatnesh Pharma Private Limited (since 2021). The company operates in Pharma. Yatnesh Pharma Private Limited reported revenue of ₹69.60 Cr (FY 2025).

DIN 09378445
Primary Designation Director
Industry Pharma
First Appointment 25 Sep 2021
Oldest Company Age 13 yrs
Largest company Yatnesh Pharma Private Limited · ₹69.60 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yatnesh Pharma Private Limited U85100DL2013PTC255862
Director25 Sep 20212013₹69.60 Cr (FY 2025)Active

Board colleagues of Bimla Garg

NameDINCompanyDesignation
Bhupender Kumar06590583Yatnesh Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yatnesh Pharma Private Limited
Premium access

Shareholding and investment profile for Bimla Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bimla Garg

Bimla Garg currently holds 1 directorship: Yatnesh Pharma Private Limited (Director, since 25 Sep 2021, revenue ₹69.60 Cr (FY 2025)).

Bimla Garg was first appointed on 25 Sep 2021 as Director at Yatnesh Pharma Private Limited.

The current boards of Bimla Garg's companies include Bhupender Kumar (Yatnesh Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available